Scotsman | Non-Hodgkin lymphoma survival doubles since early 1970s Medical Xpress These vast improvements are largely thanks to better treatments – particularly the drug rituximab, which Cancer Research UK scientists laid the groundwork for with their early work into the immune system – and earlier diagnosis linked to improved ... New treatments see blood cancer survival rates up |
